id	sid	eid	entity	type
bptjm-57	1	1	berkeley pharma tech journal	ORG
bptjm-57	1	2	august 11	DATE
bptjm-57	1	3	2023	CARDINAL
bptjm-57	1	4	april 5	DATE
bptjm-57	1	5	2024	DATE
bptjm-57	1	6	2024	DATE
bptjm-57	1	7	4.0	CARDINAL
bptjm-57	7	1	patricia gonzaga	PERSON
bptjm-57	7	2	noelie macmullan	PERSON
bptjm-57	7	3	jason park	GPE
bptjm-57	7	4	m.s. 1	ORG
bptjm-57	7	5	one	CARDINAL
bptjm-57	7	6	three	CARDINAL
bptjm-57	7	7	2022	CARDINAL
bptjm-57	7	8	607,790	CARDINAL
bptjm-57	7	9	u.s.1	ORG
bptjm-57	7	10	2023	CARDINAL
bptjm-57	7	11	609,820	CARDINAL
bptjm-57	7	12	roughly 2 million	CARDINAL
bptjm-57	7	13	u.s.	GPE
bptjm-57	7	14	cancer.2	PRODUCT
bptjm-57	8	1	one	CARDINAL
bptjm-57	10	1	u.s.	GPE
bptjm-57	10	2	two	CARDINAL
bptjm-57	11	1	the wellcome trust sanger institute	ORG
bptjm-57	11	2	4,938,362	CARDINAL
bptjm-57	11	3	7,042	CARDINAL
bptjm-57	11	4	more than 20	CARDINAL
bptjm-57	15	1	intratumor heterogeneity	PERSON
bptjm-57	15	2	today	DATE
bptjm-57	17	1	one	CARDINAL
bptjm-57	17	2	berkeley pharma tech journal	ORG
bptjm-57	17	3	84	CARDINAL
bptjm-57	22	1	recent years	DATE
bptjm-57	28	1	berkeley pharma tech journal	ORG
bptjm-57	28	2	85	CARDINAL
bptjm-57	29	1	2	CARDINAL
bptjm-57	29	2	2.1	CARDINAL
bptjm-57	29	3	two	CARDINAL
bptjm-57	30	1	1	CARDINAL
bptjm-57	31	1	alterations9	PERSON
bptjm-57	31	2	time11	GPE
bptjm-57	31	3	one	CARDINAL
bptjm-57	31	4	environments15	ORG
bptjm-57	31	5	defects9	ORG
bptjm-57	31	6	processes12	NORP
bptjm-57	31	7	microenvironment13	PERSON
bptjm-57	31	8	cells13	GPE
bptjm-57	31	9	emt	ORG
bptjm-57	31	10	emt	ORG
bptjm-57	31	11	zeb1	ORG
bptjm-57	31	12	berkeley pharma tech journal	ORG
bptjm-57	32	1	86	CARDINAL
bptjm-57	32	2	grow14	ORG
bptjm-57	32	3	tumor14	ORG
bptjm-57	32	4	1	CARDINAL
bptjm-57	35	1	four	CARDINAL
bptjm-57	35	2	intratumor	ORG
bptjm-57	36	1	four	CARDINAL
bptjm-57	38	1	three	CARDINAL
bptjm-57	39	1	two	CARDINAL
bptjm-57	39	2	two	CARDINAL
bptjm-57	42	1	berkeley pharma tech journal	ORG
bptjm-57	42	2	87	CARDINAL
bptjm-57	42	3	1	CARDINAL
bptjm-57	44	1	two	CARDINAL
bptjm-57	48	1	intratumor heterogeneity	PERSON
bptjm-57	49	1	2.2	CARDINAL
bptjm-57	50	1	brca1	GPE
bptjm-57	50	2	brca2, tp53	ORG
bptjm-57	50	3	kras	ORG
bptjm-57	50	4	berkeley pharma tech journal	ORG
bptjm-57	50	5	88	CARDINAL
bptjm-57	51	1	one	CARDINAL
bptjm-57	51	2	khosr2	GPE
bptjm-57	54	1	22,23	CARDINAL
bptjm-57	56	1	2	CARDINAL
bptjm-57	57	1	brca1	GPE
bptjm-57	57	2	brca2, tp53, her2/neu mutations18	ORG
bptjm-57	57	3	kras mutations	PERSON
bptjm-57	57	4	alk rearrangements	PERSON
bptjm-57	57	5	apc	ORG
bptjm-57	57	6	kras, tp53	ORG
bptjm-57	57	7	mutations25	PERSON
bptjm-57	57	8	berkeley pharma tech journal	ORG
bptjm-57	57	9	89	CARDINAL
bptjm-57	57	10	ar alterations27	ORG
bptjm-57	57	11	2	CARDINAL
bptjm-57	60	1	1	CARDINAL
bptjm-57	60	2	2	CARDINAL
bptjm-57	63	1	2.3	CARDINAL
bptjm-57	66	1	three	CARDINAL
bptjm-57	66	2	berkeley pharma tech journal	ORG
bptjm-57	66	3	90	CARDINAL
bptjm-57	66	4	tith40	GPE
bptjm-57	68	1	25	CARDINAL
bptjm-57	68	2	10,000	CARDINAL
bptjm-57	69	1	depth2	PERSON
bptjm-57	69	2	2022	CARDINAL
bptjm-57	71	1	one	CARDINAL
bptjm-57	72	1	one	CARDINAL
bptjm-57	72	2	255	CARDINAL
bptjm-57	72	3	291	CARDINAL
bptjm-57	72	4	3	CARDINAL
bptjm-57	73	1	2012	DATE
bptjm-57	73	2	berkeley pharma tech journal	ORG
bptjm-57	73	3	91	CARDINAL
bptjm-57	73	4	intratumor	ORG
bptjm-57	73	5	tp53	ORG
bptjm-57	73	6	2013	DATE
bptjm-57	73	7	2014	DATE
bptjm-57	73	8	2015	CARDINAL
bptjm-57	73	9	tith40	ORG
bptjm-57	73	10	2016	DATE
bptjm-57	73	11	2020	DATE
bptjm-57	73	12	2022	CARDINAL
bptjm-57	73	13	3	CARDINAL
bptjm-57	75	1	the year	DATE
bptjm-57	78	1	berkeley pharma tech journal	ORG
bptjm-57	78	2	92	CARDINAL
bptjm-57	79	1	2020	DATE
bptjm-57	79	2	thousands	CARDINAL
bptjm-57	79	3	previous years	DATE
bptjm-57	83	1	challenges.46 2.4	FAC
bptjm-57	85	1	one	CARDINAL
bptjm-57	87	1	20	CARDINAL
bptjm-57	87	2	nac	ORG
bptjm-57	91	1	emt	ORG
bptjm-57	91	2	48	CARDINAL
bptjm-57	91	3	berkeley pharma tech journal	ORG
bptjm-57	91	4	93	CARDINAL
bptjm-57	92	1	three	CARDINAL
bptjm-57	93	1	cetuximab	PERSON
bptjm-57	95	1	tgf-α	ORG
bptjm-57	95	2	amphiregulin	PERSON
bptjm-57	96	1	microenvironment.49 3	DATE
bptjm-57	97	1	3.1	CARDINAL
bptjm-57	99	1	modulators.50,51	PRODUCT
bptjm-57	99	2	recent years	DATE
bptjm-57	102	1	berkeley pharma tech journal	ORG
bptjm-57	102	2	94	CARDINAL
bptjm-57	104	1	2	CARDINAL
bptjm-57	111	1	one	CARDINAL
bptjm-57	111	2	fred hutchinson	PERSON
bptjm-57	111	3	2016-2021	DATE
bptjm-57	114	1	one	CARDINAL
bptjm-57	114	2	three	CARDINAL
bptjm-57	114	3	2	CARDINAL
bptjm-57	114	4	one	CARDINAL
bptjm-57	114	5	six	CARDINAL
bptjm-57	114	6	3	CARDINAL
bptjm-57	114	7	one year	DATE
bptjm-57	114	8	38.89%	PERCENT
bptjm-57	114	9	second	ORDINAL
bptjm-57	114	10	the national natural science foundation of china	ORG
bptjm-57	114	11	nanjing	GPE
bptjm-57	115	1	msln	PERSON
bptjm-57	116	1	berkeley pharma tech journal	ORG
bptjm-57	116	2	95	CARDINAL
bptjm-57	117	1	18.3%	PERCENT
bptjm-57	117	2	1.81%	PERCENT
bptjm-57	117	3	anti-ɑ	NORP
bptjm-57	118	1	third	ORDINAL
bptjm-57	119	1	2019	DATE
bptjm-57	119	2	late 2023/early 2024	DATE
bptjm-57	120	1	2	CARDINAL
bptjm-57	127	1	berkeley pharma tech journal	ORG
bptjm-57	127	2	96	CARDINAL
bptjm-57	128	1	1	CARDINAL
bptjm-57	128	2	1	CARDINAL
bptjm-57	130	1	one	CARDINAL
bptjm-57	130	2	seven	CARDINAL
bptjm-57	130	3	fda	ORG
bptjm-57	130	4	bristol-myers squibb	ORG
bptjm-57	130	5	2016-2023	CARDINAL
bptjm-57	130	6	nivolumab	PERSON
bptjm-57	130	7	cisplatin	PERSON
bptjm-57	131	1	four months	DATE
bptjm-57	132	1	76.6%	PERCENT
bptjm-57	132	2	85.1%	PERCENT
bptjm-57	132	3	respectively.57	GPE
bptjm-57	132	4	three-year	DATE
bptjm-57	132	5	23% and 15%	PERCENT
bptjm-57	133	1	three years	DATE
bptjm-57	133	2	28%	PERCENT
bptjm-57	133	3	0%	PERCENT
bptjm-57	134	1	berkeley pharma tech journal	ORG
bptjm-57	134	2	97	CARDINAL
bptjm-57	134	3	3	CARDINAL
bptjm-57	135	1	apc	ORG
bptjm-57	136	1	apc	ORG
bptjm-57	137	1	cd28	ORG
bptjm-57	138	1	cd28	ORG
bptjm-57	142	1	cd28	ORG
bptjm-57	143	1	anti-pd-l1	NORP
bptjm-57	143	2	pd-l1	GPE
bptjm-57	145	1	3.2	CARDINAL
bptjm-57	147	1	berkeley pharma tech journal	ORG
bptjm-57	147	2	98	CARDINAL
bptjm-57	150	1	one	CARDINAL
bptjm-57	150	2	2018	DATE
bptjm-57	150	3	canadian	NORP
bptjm-57	150	4	ms-275	ORG
bptjm-57	153	1	andms-275	DATE
bptjm-57	153	2	bristol myers squibb	ORG
bptjm-57	153	3	2018	DATE
bptjm-57	154	1	85%	PERCENT
bptjm-57	154	2	58%	PERCENT
bptjm-57	154	3	one year	DATE
bptjm-57	154	4	2018-2024	DATE
bptjm-57	154	5	medimmune llc	GPE
bptjm-57	156	1	1	CARDINAL
bptjm-57	156	2	80%	PERCENT
bptjm-57	156	3	21.9 months	DATE
bptjm-57	157	1	2	CARDINAL
bptjm-57	157	2	1	CARDINAL
bptjm-57	157	3	81%	PERCENT
bptjm-57	157	4	24.8 months	DATE
bptjm-57	157	5	twenty-eight days	DATE
bptjm-57	158	1	ninety days	DATE
bptjm-57	159	1	berkeley pharma tech journal	ORG
bptjm-57	159	2	99 one	CARDINAL
bptjm-57	159	3	1	CARDINAL
bptjm-57	159	4	1	CARDINAL
bptjm-57	160	1	3.3	CARDINAL
bptjm-57	160	2	two	CARDINAL
bptjm-57	164	1	epcoritamab	PERSON
bptjm-57	164	2	cd20	PRODUCT
bptjm-57	166	1	157	CARDINAL
bptjm-57	166	2	63.1%.64an	CARDINAL
bptjm-57	166	3	60%	PERCENT
bptjm-57	166	4	3	CARDINAL
bptjm-57	166	5	38.9%	PERCENT
bptjm-57	166	6	2.7 months	DATE
bptjm-57	167	1	epcoritamab	PERSON
bptjm-57	167	2	nine	CARDINAL
bptjm-57	168	1	68%	PERCENT
bptjm-57	170	1	berkeley pharma tech journal	ORG
bptjm-57	170	2	100	CARDINAL
bptjm-57	172	1	cheung	PERSON
bptjm-57	172	2	two	CARDINAL
bptjm-57	174	1	her2-	PERSON
bptjm-57	174	2	steap1	ORG
bptjm-57	174	3	only one	CARDINAL
bptjm-57	177	1	loss.67	LOC
bptjm-57	182	1	berkeley pharma tech journal	ORG
bptjm-57	183	1	101	CARDINAL
bptjm-57	184	1	3.4	CARDINAL
bptjm-57	184	2	rnas	PERSON
bptjm-57	185	1	one	CARDINAL
bptjm-57	186	1	liu et al.	PERSON
bptjm-57	187	1	nanornp	PERSON
bptjm-57	189	1	cas9	GPE
bptjm-57	190	1	cas9	GPE
bptjm-57	191	1	nanornps	PERSON
bptjm-57	191	2	liu et al	PERSON
bptjm-57	191	3	stat3	ORG
bptjm-57	191	4	runx1	PERSON
bptjm-57	192	1	nanornp-stat3+runx1	ORG
bptjm-57	194	1	berkeley pharma tech journal	ORG
bptjm-57	194	2	102	CARDINAL
bptjm-57	194	3	only one	CARDINAL
bptjm-57	195	1	stat3	ORG
bptjm-57	195	2	runx1	ORG
bptjm-57	197	1	3.5	CARDINAL
bptjm-57	200	1	2d	DATE
bptjm-57	201	1	2d	CARDINAL
bptjm-57	203	1	zero	CARDINAL
bptjm-57	203	2	structure.71,72	ORG
bptjm-57	205	1	berkeley pharma tech journal	ORG
bptjm-57	205	2	103	CARDINAL
bptjm-57	206	1	biopsies70	ORG
bptjm-57	206	2	ctc	ORG
bptjm-57	206	3	blood.70	ORG
bptjm-57	206	4	59	CARDINAL
bptjm-57	206	5	ctc	ORG
bptjm-57	207	1	less than three	CARDINAL
bptjm-57	208	1	0	CARDINAL
bptjm-57	208	2	5	CARDINAL
bptjm-57	208	3	7	CARDINAL
bptjm-57	208	4	7.5 ml	QUANTITY
bptjm-57	208	5	65.2%	PERCENT
bptjm-57	208	6	78.4%	PERCENT
bptjm-57	208	7	87.5%	PERCENT
bptjm-57	208	8	respectively.73	ORG
bptjm-57	208	9	ctc	ORG
bptjm-57	208	10	models.71 4	ORG
bptjm-57	214	1	ctc	ORG
bptjm-57	216	1	berkeley pharma tech journal	ORG
bptjm-57	218	1	one	CARDINAL
bptjm-57	223	1	5	CARDINAL
bptjm-57	229	1	berkeley pharma tech journal	ORG
bptjm-57	230	1	105	CARDINAL
bptjm-57	231	1	berkeley pharma tech journal	ORG
bptjm-57	231	2	106	CARDINAL
bptjm-57	231	3	1	CARDINAL
bptjm-57	232	1	ahmad	PERSON
bptjm-57	232	2	cisewski ja	PERSON
bptjm-57	233	1	xu j	PERSON
bptjm-57	233	2	anderson rn.	PERSON
bptjm-57	233	3	united states	GPE
bptjm-57	233	4	2022.mmwrmorbmortalwkly	CARDINAL
bptjm-57	233	5	2023;72(18):488	CARDINAL
bptjm-57	235	1	2	CARDINAL
bptjm-57	236	1	national cancer institute	ORG
bptjm-57	237	1	july 17	DATE
bptjm-57	237	2	2023	CARDINAL
bptjm-57	239	1	3	CARDINAL
bptjm-57	241	1	july 17	DATE
bptjm-57	241	2	2023	CARDINAL
bptjm-57	243	1	4	CARDINAL
bptjm-57	246	1	july 17	DATE
bptjm-57	246	2	2023	CARDINAL
bptjm-57	248	1	5	CARDINAL
bptjm-57	248	2	alexandrov lb	PERSON
bptjm-57	248	3	nik-zainal s	PERSON
bptjm-57	248	4	wedge dc	GPE
bptjm-57	249	1	2013	DATE
bptjm-57	249	2	oct 10;502(7470):258	DATE
bptjm-57	250	1	imielinsk	ORG
bptjm-57	250	2	marcin	PERSON
bptjm-57	250	3	2013;500(7463):415-421	CARDINAL
bptjm-57	251	1	doi:10.1038/nature12477	ORG
bptjm-57	252	1	6	CARDINAL
bptjm-57	252	2	zhao x	PERSON
bptjm-57	253	1	plos computational	PERSON
bptjm-57	254	1	2014;10(7):e1003664	CARDINAL
bptjm-57	254	2	10.1371	CARDINAL
bptjm-57	255	1	ramón	PERSON
bptjm-57	257	1	j molmed	PERSON
bptjm-57	257	2	berl	ORG
bptjm-57	258	1	2020;98(2):161-177	CARDINAL
bptjm-57	260	1	alizadeh aa	PERSON
bptjm-57	260	2	aranda v	PERSON
bptjm-57	263	1	2015;21(8):846-853	CARDINAL
bptjm-57	264	1	9	CARDINAL
bptjm-57	265	1	jiao y	PERSON
bptjm-57	265	2	li s	PERSON
bptjm-57	265	3	wang x	PERSON
bptjm-57	268	1	2022;13:929846	CARDINAL
bptjm-57	268	2	mmu.2022.929846	LOC
bptjm-57	268	3	10	CARDINAL
bptjm-57	269	1	el-sayes	ORG
bptjm-57	270	1	mossman k.	PERSON
bptjm-57	272	1	2021;13(4):806	CARDINAL
bptjm-57	274	1	11	CARDINAL
bptjm-57	274	2	mission bio	FAC
bptjm-57	274	3	august 11	DATE
bptjm-57	274	4	2023	CARDINAL
bptjm-57	275	1	12	CARDINAL
bptjm-57	276	1	greaves m	PERSON
bptjm-57	276	2	maley cc	PERSON
bptjm-57	277	1	2012;481(7381):306-313	DATE
bptjm-57	277	2	10.1038	CARDINAL
bptjm-57	278	1	anderson	PERSON
bptjm-57	280	1	curr	ORG
bptjm-57	281	1	2020;30(16):r921	CARDINAL
bptjm-57	281	2	doi:10.1016/j.cub.2020.06.081	ORG
bptjm-57	282	1	14	DATE
bptjm-57	283	1	jiang x	PERSON
bptjm-57	283	2	wang j	PERSON
bptjm-57	283	3	deng x	PERSON
bptjm-57	286	1	2020;39(1):204	ORG
bptjm-57	287	1	15	CARDINAL
bptjm-57	288	1	gupta pb	PERSON
bptjm-57	288	2	berkeley pharma tech journal	ORG
bptjm-57	288	3	107	CARDINAL
bptjm-57	290	1	2019;24(1):65	CARDINAL
bptjm-57	291	1	doi:10.1016/j.stem.2018.11.011	ORG
bptjm-57	292	1	16	CARDINAL
bptjm-57	292	2	wum	ORG
bptjm-57	292	3	zhang x	PERSON
bptjm-57	293	1	2022;13:1371	CARDINAL
bptjm-57	293	2	doi:10.1038	ORG
bptjm-57	293	3	17	CARDINAL
bptjm-57	293	4	papadopoulos n	PERSON
bptjm-57	293	5	zhou s	PERSON
bptjm-57	293	6	diaz la jr	PERSON
bptjm-57	295	1	2013;339(6127):1546-1558	CARDINAL
bptjm-57	296	1	18	CARDINAL
bptjm-57	297	1	feng y	PERSON
bptjm-57	297	2	spezia	NORP
bptjm-57	297	3	huang s	PERSON
bptjm-57	299	1	2018;5(2):77	CARDINAL
bptjm-57	299	2	doi:10.1016/j.gendis.2018.05.001	ORG
bptjm-57	300	1	19	CARDINAL
bptjm-57	301	1	chandran c. egfrmutations	PERSON
bptjm-57	301	2	alk	PERSON
bptjm-57	301	3	south india	LOC
bptjm-57	303	1	2020;3(6):e1288	CARDINAL
bptjm-57	305	1	20	CARDINAL
bptjm-57	306	1	boch c	ORG
bptjm-57	306	2	roth	PERSON
bptjm-57	307	1	central europe	LOC
bptjm-57	309	1	2013;3(4):e002560	CARDINAL
bptjm-57	310	1	bmjopen-2013-002560	DATE
bptjm-57	311	1	21	DATE
bptjm-57	312	1	wang s	PERSON
bptjm-57	312	2	lin	PERSON
bptjm-57	312	3	ji g. applications	PERSON
bptjm-57	312	4	crispr/cas9	ORG
bptjm-57	313	1	bmc	ORG
bptjm-57	313	2	disord	ORG
bptjm-57	314	1	2021;22(1):149	CARDINAL
bptjm-57	315	1	22	CARDINAL
bptjm-57	316	1	kumar b	PERSON
bptjm-57	316	2	bhat-nakshatri p	ORG
bptjm-57	318	1	2018;78(17):5107-5123	CARDINAL
bptjm-57	319	1	doi:10.1158/0008-5472.can-18-0509	ORG
bptjm-57	320	1	23	CARDINAL
bptjm-57	321	1	wahler j	PERSON
bptjm-57	321	2	suh n.	PERSON
bptjm-57	322	1	curr pharmacol rep	ORG
bptjm-57	322	2	2015;1(5):324-335	CARDINAL
bptjm-57	324	1	kanazawa h	ORG
bptjm-57	324	2	ino-oka n	GPE
bptjm-57	324	3	j pathol	PERSON
bptjm-57	326	1	doi:10.1016	NORP
bptjm-57	327	1	jauhri m	PERSON
bptjm-57	327	2	nras	ORG
bptjm-57	327	3	tp53	ORG
bptjm-57	327	4	indian	NORP
bptjm-57	329	1	2017;39(2):1010428317692265	CARDINAL
bptjm-57	330	1	26	CARDINAL
bptjm-57	331	1	krishna s	PERSON
bptjm-57	331	2	lowery fj	GPE
bptjm-57	331	3	copeland ar	ORG
bptjm-57	333	1	2020;370(6522):1328-1334	CARDINAL
bptjm-57	335	1	27	CARDINAL
bptjm-57	336	1	fonseca-alves ce	ORG
bptjm-57	336	2	kobayashi pe	PERSON
bptjm-57	336	3	mdm2	PERSON
bptjm-57	336	4	2016;106:56-61	CARDINAL
bptjm-57	337	1	doi:10.1016	GPE
bptjm-57	338	1	berkeley pharma tech journal	ORG
bptjm-57	338	2	108 28	CARDINAL
bptjm-57	339	1	ellis l, lodam	PERSON
bptjm-57	341	1	sci u s a. 2015;112(47):14406-14407	ORG
bptjm-57	343	1	29	CARDINAL
bptjm-57	344	1	mei w	GPE
bptjm-57	344	2	lin x	PERSON
bptjm-57	344	3	kapoor	PERSON
bptjm-57	344	4	gu y,	PERSON
bptjm-57	344	5	zhao k	PERSON
bptjm-57	346	1	2019;11(4):434	CARDINAL
bptjm-57	348	1	30	CARDINAL
bptjm-57	349	1	watanabe t, yokoo h	PERSON
bptjm-57	349	2	yonekawa y	PERSON
bptjm-57	349	3	kleihues	PERSON
bptjm-57	349	4	tp53	ORG
bptjm-57	350	1	j neuropathol exp	PERSON
bptjm-57	351	1	2001;60(12):1181-1189	ORG
bptjm-57	354	1	yoshida h, adachi h	ORG
bptjm-57	354	2	hamada y	PERSON
bptjm-57	355	1	types.acta	DATE
bptjm-57	356	1	1988;38(3):325-338	CARDINAL
bptjm-57	357	1	doi:10.1111/j.1440-1827.1988.tb02305.x	ORG
bptjm-57	358	1	32	CARDINAL
bptjm-57	359	1	egyhazi s	ORG
bptjm-57	359	2	ringborg u	GPE
bptjm-57	359	3	hansson j. human	PERSON
bptjm-57	359	4	nras	ORG
bptjm-57	361	1	2008;1(4):395	CARDINAL
bptjm-57	362	1	doi:10.1016	GPE
bptjm-57	363	1	33	DATE
bptjm-57	364	1	weiss j	PERSON
bptjm-57	364	2	heine m	PERSON
bptjm-57	364	3	kc	PERSON
bptjm-57	364	4	1995;139:137-154	CARDINAL
bptjm-57	366	1	34	CARDINAL
bptjm-57	367	1	pawlikowska	PERSON
bptjm-57	367	2	jędrzejewski t, slominski	PERSON
bptjm-57	367	3	brożyna aa	PERSON
bptjm-57	367	4	wrotek s. pigmentation	PERSON
bptjm-57	368	1	j mol sci	PERSON
bptjm-57	371	1	35	DATE
bptjm-57	371	2	brownna	ORG
bptjm-57	371	3	plou	GPE
bptjm-57	371	4	e kr	PERSON
bptjm-57	371	5	yilmaz o	GPE
bptjm-57	372	1	sinonasal	ORG
bptjm-57	373	1	2021;34(6):1133-1142	CARDINAL
bptjm-57	374	1	doi:10.1038	ORG
bptjm-57	374	2	020	CARDINAL
bptjm-57	375	1	carcinomas.nat	CARDINAL
bptjm-57	376	1	2018;18(9):549	CARDINAL
bptjm-57	377	1	doi:10.1038	ORG
bptjm-57	377	2	37	DATE
bptjm-57	378	1	nagasawa s	ORG
bptjm-57	378	2	kashima y	GPE
bptjm-57	378	3	suzuki y.	ORG
bptjm-57	379	1	inflammregen.	ORG
bptjm-57	380	1	2021;41(1):22	CARDINAL
bptjm-57	381	1	li m	PERSON
bptjm-57	381	2	zhang z	PERSON
bptjm-57	381	3	li l	PERSON
bptjm-57	381	4	wang x.	PERSON
bptjm-57	382	1	2022mar 31;5(1):323	CARDINAL
bptjm-57	384	1	2020;3(1):505.doi:10.1038	CARDINAL
bptjm-57	385	1	39	DATE
bptjm-57	386	1	wang x. depth2:	PERSON
bptjm-57	386	2	intratumor	PRODUCT
bptjm-57	388	1	2022	CARDINAL
bptjm-57	388	2	1;20(1):150	CARDINAL
bptjm-57	389	1	10.1186	CARDINAL
bptjm-57	389	2	022-03355-1	CARDINAL
bptjm-57	390	1	lim s	PERSON
bptjm-57	390	2	nam jw	PERSON
bptjm-57	390	3	kim s.	PERSON
bptjm-57	391	1	sci berkeley pharma tech journal	ORG
bptjm-57	391	2	109	CARDINAL
bptjm-57	391	3	2016;6:37767	CARDINAL
bptjm-57	392	1	doi:10.1038/srep37767	ORG
bptjm-57	393	1	41	CARDINAL
bptjm-57	394	1	liu c	PERSON
bptjm-57	394	2	wang f	PERSON
bptjm-57	396	1	frontmed	ORG
bptjm-57	397	1	2022;9:925661	CARDINAL
bptjm-57	399	1	42	CARDINAL
bptjm-57	400	1	carter sl	PERSON
bptjm-57	400	2	cibulskis k	PERSON
bptjm-57	400	3	helman e	GPE
bptjm-57	402	1	2012;30(5):413-421	CARDINAL
bptjm-57	403	1	doi:10.1038	ORG
bptjm-57	403	2	43	CARDINAL
bptjm-57	403	3	mroz ea	PERSON
bptjm-57	403	4	rocco jw.math	PERSON
bptjm-57	404	1	2013;49(3):211-215	CARDINAL
bptjm-57	405	1	44	DATE
bptjm-57	406	1	müller s	PERSON
bptjm-57	408	1	2014;30(1):50-60	CARDINAL
bptjm-57	409	1	45	CARDINAL
bptjm-57	409	2	jang gh	PERSON
bptjm-57	409	3	stein l	ORG
bptjm-57	409	4	morris q.	PERSON
bptjm-57	410	1	2015;16(1):35	CARDINAL
bptjm-57	411	1	46	DATE
bptjm-57	412	1	ding s	PERSON
bptjm-57	412	2	chen x	PERSON
bptjm-57	412	3	shen k. single-cell	PERSON
bptjm-57	413	1	commun	PERSON
bptjm-57	413	2	lond	PERSON
bptjm-57	414	1	2020;40(8):329-344	CARDINAL
bptjm-57	417	1	kim c	PERSON
bptjm-57	417	2	gao r	PERSON
bptjm-57	419	1	2018;173(4):879-893.e13	DATE
bptjm-57	419	2	doi:10.1016/j.cell.2018.03.041	GPE
bptjm-57	420	1	48	DATE
bptjm-57	420	2	b.	PERSON
bptjm-57	420	3	perry	GPE
bptjm-57	420	4	m.w. d.	GPE
bptjm-57	420	5	j. r.	PERSON
bptjm-57	420	6	andré, f., & okkenhaug	PERSON
bptjm-57	420	7	k. pi3k	PERSON
bptjm-57	420	8	age.nat rev drug	ORG
bptjm-57	421	1	2021;20(10	CARDINAL
bptjm-57	422	1	741–769	CARDINAL
bptjm-57	422	2	doi:10.1038	ORG
bptjm-57	422	3	49	DATE
bptjm-57	423	1	hobor	PERSON
bptjm-57	423	2	van emburgh bo	PERSON
bptjm-57	423	3	crowley e	PERSON
bptjm-57	423	4	di nicolantonio f	PERSON
bptjm-57	423	5	a. tgfα	PERSON
bptjm-57	425	1	2014;20(24):6429-6438	DATE
bptjm-57	427	1	50	CARDINAL
bptjm-57	427	2	national cancer institute	ORG
bptjm-57	429	1	national cancer institute	ORG
bptjm-57	430	1	september 24, 2019	DATE
bptjm-57	431	1	august 11	DATE
bptjm-57	431	2	2023	CARDINAL
bptjm-57	433	1	51	CARDINAL
bptjm-57	434	1	dessie terefe g	PERSON
bptjm-57	434	2	tadele admasu	PERSON
bptjm-57	434	3	wale tesega w	PERSON
bptjm-57	434	4	chekol abebe e.	PERSON
bptjm-57	437	1	doi:10.1080/21645515.2022.2114254	ORG
bptjm-57	438	1	ctg	ORG
bptjm-57	439	1	july 27	DATE
bptjm-57	439	2	2023	CARDINAL
bptjm-57	440	1	https://clinicaltrials.gov/study/nct02706392	GPE
bptjm-57	441	1	53	CARDINAL
bptjm-57	442	1	kirtane k	PERSON
bptjm-57	442	2	chung ch	PERSON
bptjm-57	444	1	2021;9(7):e002723	CARDINAL
bptjm-57	444	2	doi:10.1136/jitc-2021-002723	ORG
bptjm-57	445	1	berkeley pharma tech journal	ORG
bptjm-57	445	2	110 54	DATE
bptjm-57	446	1	yang f	PERSON
bptjm-57	446	2	zhang f	PERSON
bptjm-57	448	1	2023;14:1175920	CARDINAL
bptjm-57	451	1	ctg	ORG
bptjm-57	452	1	july 27	DATE
bptjm-57	452	2	2023	CARDINAL
bptjm-57	453	1	56	DATE
bptjm-57	453	2	naimi a,	PERSON
bptjm-57	453	3	mohammed rn	PERSON
bptjm-57	456	1	2022;20(1):44	CARDINAL
bptjm-57	456	2	57	CARDINAL
bptjm-57	457	1	ctg	ORG
bptjm-57	458	1	august 8	DATE
bptjm-57	458	2	2023	CARDINAL
bptjm-57	459	1	9?term	CARDINAL
bptjm-57	459	2	58	CARDINAL
bptjm-57	460	1	first	ORDINAL
bptjm-57	460	2	3-year	DATE
bptjm-57	460	3	743	CARDINAL
bptjm-57	461	1	ann oncol	PERSON
bptjm-57	462	1	2022;33(5):488-499	CARDINAL
bptjm-57	463	1	doi:10.1016/j.annonc.2022.01.074	ORG
bptjm-57	464	1	59	CARDINAL
bptjm-57	465	1	bayat mokhtari	PERSON
bptjm-57	466	1	2017;8(23):38022-38043	CARDINAL
bptjm-57	467	1	60	CARDINAL
bptjm-57	468	1	nguyen a	PERSON
bptjm-57	468	2	ho la	PERSON
bptjm-57	468	3	workenhe st	PERSON
bptjm-57	471	1	2018;24(3):642-654	CARDINAL
bptjm-57	472	1	40	CARDINAL
bptjm-57	473	1	ariyan ce	PERSON
bptjm-57	473	2	bradyms	GPE
bptjm-57	475	1	2018;6(2):189-200	CARDINAL
bptjm-57	476	1	doi:10.1158/2326-6066.cir-17-0356	CARDINAL
bptjm-57	477	1	62	DATE
bptjm-57	478	1	ctg	ORG
bptjm-57	479	1	august 9	DATE
bptjm-57	479	2	2023	CARDINAL
bptjm-57	480	1	https://clinicaltrials.gov/study/nct033812	ORG
bptjm-57	480	2	74?term	CARDINAL
bptjm-57	480	3	anc	ORG
bptjm-57	481	1	63	CARDINAL
bptjm-57	482	1	kamakura	PERSON
bptjm-57	482	2	asano	ORG
bptjm-57	482	3	yasunaga m. t	PERSON
bptjm-57	484	1	2021;14(11):1172	CARDINAL
bptjm-57	485	1	64	CARDINAL
bptjm-57	486	1	phillips t	PERSON
bptjm-57	486	2	epcoritamab	PERSON
bptjm-57	490	1	65	CARDINAL
bptjm-57	492	1	the food and drug administration	ORG
bptjm-57	494	1	2022;22(1):277	CARDINAL
bptjm-57	497	1	first	ORDINAL
bptjm-57	498	1	j clin oncol	PERSON
bptjm-57	499	1	2022;40(31):3576-3586	CARDINAL
bptjm-57	500	1	berkeley pharma tech journal	ORG
bptjm-57	500	2	111	CARDINAL
bptjm-57	500	3	https://clinicaltrials.gov/study/nct03873805 https://clinicaltrials.gov/study/nct03873805	EVENT
bptjm-57	502	1	park ja	PERSON
bptjm-57	502	2	cheung	PERSON
bptjm-57	505	1	2022;10(1):e003771	CARDINAL
bptjm-57	506	1	68	CARDINAL
bptjm-57	506	2	patra jk	ORG
bptjm-57	506	3	das g	PERSON
bptjm-57	509	1	2018;16(1):71	CARDINAL
bptjm-57	511	1	liu	PERSON
bptjm-57	511	2	cai j	PERSON
bptjm-57	511	3	zheng y	PERSON
bptjm-57	511	4	nanornp	PERSON
bptjm-57	512	1	2019;19(11):7662-7672	DATE
bptjm-57	514	1	70	CARDINAL
bptjm-57	516	1	biophys acta	PERSON
bptjm-57	517	1	2018;1869(2):117	CARDINAL
bptjm-57	518	1	doi:10.1016	GPE
bptjm-57	519	1	71	CARDINAL
bptjm-57	521	1	cleveland clinic	ORG
bptjm-57	522	1	23992	DATE
bptjm-57	522	2	72	DATE
bptjm-57	523	1	lin d	PERSON
bptjm-57	525	1	2021;6(1):404	CARDINAL
bptjm-57	525	2	doi:10.1038	ORG
bptjm-57	527	1	qiao y	PERSON
bptjm-57	527	2	li j	PERSON
bptjm-57	529	1	onco	PERSON
bptjm-57	532	1	zhou y, yang d	PERSON
bptjm-57	532	2	yang	PERSON
bptjm-57	532	3	nat commun	PERSON
bptjm-57	533	1	2021	CARDINAL
bptjm-57	533	2	30;12(1):2567].nat commun	TIME
bptjm-57	534	1	2020;11(1):6322	DATE
bptjm-57	534	2	doi:10.1038	ORG
bptjm-57	536	1	cooke sl	PERSON
bptjm-57	541	1	berkeley pharma tech journal	ORG
bptjm-57	541	2	112 https://my.clevelandclinic.org/health/diagnostics/23992-liquid-biopsy https://my.clevelandclinic.org/health/diagnostics/23992-liquid-biopsy	DATE